ArticleBrain & spine2025
Functional-guided frameless stereotactic biopsy of highly eloquent brain tumors.
Article in Brain & spine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Regarding diagnostics and treatment planning, intracranial mass lesions often require needle biopsies. Despite being performed with minimum invasiveness, biopsy-related functional deficits may still occur. Navigated transcranial magnetic stimulation (nTMS) enables preoperative non-invasive identification of eloquent brain areas. In addition, nTMS-based tractography can visualize eloquent white matter pathways. This study evaluated the usefulness and clinical impact of non-invasive cortical mapping and tractography of eloquent brain functions for trajectory planning before stereotactic biopsies. Methods: Cortical nTMS data and nTMS-based tractography of motor and language function were integrated into the routine workflow of trajectory planning before biopsies. Intraoperative data, histopathological findings, and clinical outcomes were analyzed. Furthermore, a matched-pair analysis comparing cases with and without cortical nTMS data and nTMS-based tractography was performed. Results: Between March 2018 and March 2023, 45 stereotactic frameless biopsies of eloquent brain lesions with preoperative nTMS mappings and nTMS-based tractography (16 motor/2 language/27 both) were analyzed. Cortical nTMS data and tractography were considered during trajectory planning in all cases. The diagnostic yield was 84.4 %. Histopathological findings showed HGG in 25 (55.6 %) cases, low-grade-glioma in 5 (11.1 %) patients, lymphoma in 5 patients (11.1 %), and reactive gliosis to rule out tumor progression in 4 cases (8.9 %). Amongst cases with no clear histopathological finding, resection of the lesion was performed in four patients, while one patient underwent repeated biopsy. One case of language deterioration resolved after admission of corticosteroids, and two cases of progressive motor decline related to extensive tumor progress on MRI were observed during hospitalization. Postoperative computed tomography imaging in these three cases revealed no postoperative hemorrhage. In the matched cohort, the diagnostic yield was 84.4 % (p > 0.999). However, a higher rate of neurological deficits was observed (13.3 %; p = 0.292). Conclusions: Non-invasive functional data can easily be integrated into trajectory planning workflow for frameless stereotactic biopsies. The reliable visualization of eloquent cortical and subcortical regions facilitates the planning process and might avoid surgery-related neurological deficits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.